Institute of Immunobiology, Medical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland (N.C., C.G.-C., C.P.-S., B.L.).
University Heart Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland (C.G.-C., B.L.), University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Circ Res. 2024 Jun 7;134(12):1703-1717. doi: 10.1161/CIRCRESAHA.124.323892. Epub 2024 Jun 6.
Fibroblasts are essential for building and maintaining the structural integrity of all organs. Moreover, fibroblasts can acquire an inflammatory phenotype to accommodate immune cells in specific niches and to provide migration, differentiation, and growth factors. In the heart, balancing of fibroblast activity is critical for cardiac homeostasis and optimal organ function during inflammation. Fibroblasts sustain cardiac homeostasis by generating local niche environments that support housekeeping functions and by actively engaging in intercellular cross talk. During inflammatory perturbations, cardiac fibroblasts rapidly switch to an inflammatory state and actively communicate with infiltrating immune cells to orchestrate immune cell migration and activity. Here, we summarize the current knowledge on the molecular landscape of cardiac fibroblasts, focusing on their dual role in promoting tissue homeostasis and modulating immune cell-cardiomyocyte interaction. In addition, we discuss potential future avenues for manipulating cardiac fibroblast activity during myocardial inflammation.
成纤维细胞对于构建和维持所有器官的结构完整性至关重要。此外,成纤维细胞可以获得炎症表型,以适应特定龛位的免疫细胞,并提供迁移、分化和生长因子。在心脏中,平衡成纤维细胞的活性对于心脏内稳态和炎症期间的最佳器官功能至关重要。成纤维细胞通过产生支持管家功能的局部小生境环境,并积极参与细胞间的交流,来维持心脏内稳态。在炎症扰动期间,心脏成纤维细胞迅速转变为炎症状态,并与浸润的免疫细胞积极沟通,以协调免疫细胞的迁移和活性。在这里,我们总结了心脏成纤维细胞的分子图谱的最新知识,重点介绍了它们在促进组织内稳态和调节免疫细胞-心肌细胞相互作用方面的双重作用。此外,我们还讨论了在心肌炎症期间操纵心脏成纤维细胞活性的潜在未来途径。
Circ Res. 2024-6-7
J Cardiovasc Transl Res. 2012-9-27
Curr Cardiol Rep. 2025-6-17
J Mol Cell Cardiol Plus. 2025-2-19
J Clin Invest. 2025-1-16
Am J Physiol Heart Circ Physiol. 2024-9-1
Theranostics. 2024
Am J Physiol Heart Circ Physiol. 2024-2-1
J Exp Med. 2024-1-1
Adv Biol (Weinh). 2024-1
Nature. 2023-7
Circulation. 2023-7-4